Bayer and Innovative Medicines Initiative

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Bayer and Innovative Medicines Initiative

Bayer vs. Innovative Medicines Initiative

Bayer AG is a German multinational, pharmaceutical and life sciences company. The Innovative Medicines Initiative (IMI) is a European initiative to improve the competitive situation of the European Union in the field of pharmaceutical research.

Similarities between Bayer and Innovative Medicines Initiative

Bayer and Innovative Medicines Initiative have 3 things in common (in Unionpedia): European Commission, European Federation of Pharmaceutical Industries and Associations, Public–private partnership.

European Commission

The European Commission (EC) is an institution of the European Union, responsible for proposing legislation, implementing decisions, upholding the EU treaties and managing the day-to-day business of the EU.

Bayer and European Commission · European Commission and Innovative Medicines Initiative · See more »

European Federation of Pharmaceutical Industries and Associations

The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association founded in 1978 representing the research-based pharmaceutical industry operating in Europe.

Bayer and European Federation of Pharmaceutical Industries and Associations · European Federation of Pharmaceutical Industries and Associations and Innovative Medicines Initiative · See more »

Public–private partnership

A public–private partnership (PPP, 3P or P3) is a cooperative arrangement between two or more public and private sectors, typically of a long-term nature.

Bayer and Public–private partnership · Innovative Medicines Initiative and Public–private partnership · See more »

The list above answers the following questions

What Bayer and Innovative Medicines Initiative have in common
What are the similarities between Bayer and Innovative Medicines Initiative

Bayer and Innovative Medicines Initiative Comparison

Bayer has 223 relations, while Innovative Medicines Initiative has 13. As they have in common 3, the Jaccard index is 1.27% = 3 / (223 + 13).

References

This article shows the relationship between Bayer and Innovative Medicines Initiative. To access each article from which the information was extracted, please visit:

Unionpedia is a concept map or semantic network organized like an encyclopedia – dictionary. It gives a brief definition of each concept and its relationships.

This is a giant online mental map that serves as a basis for concept diagrams. It's free to use and each article or document can be downloaded. It's a tool, resource or reference for study, research, education, learning or teaching, that can be used by teachers, educators, pupils or students; for the academic world: for school, primary, secondary, high school, middle, technical degree, college, university, undergraduate, master's or doctoral degrees; for papers, reports, projects, ideas, documentation, surveys, summaries, or thesis. Here is the definition, explanation, description, or the meaning of each significant on which you need information, and a list of their associated concepts as a glossary. Available in English, Spanish, Portuguese, Japanese, Chinese, French, German, Italian, Polish, Dutch, Russian, Arabic, Hindi, Swedish, Ukrainian, Hungarian, Catalan, Czech, Hebrew, Danish, Finnish, Indonesian, Norwegian, Romanian, Turkish, Vietnamese, Korean, Thai, Greek, Bulgarian, Croatian, Slovak, Lithuanian, Filipino, Latvian, Estonian and Slovenian. More languages soon.

All the information was extracted from Wikipedia, and it's available under the Creative Commons Attribution-ShareAlike License.

Unionpedia is not endorsed by or affiliated with the Wikimedia Foundation.

Google Play, Android and the Google Play logo are trademarks of Google Inc.